Werbung
Werbung

SLDB

SLDB logo

Solid Biosciences Inc. Common Stock

5.28
USD
Gesponsert
-0.03
-0.49%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

5.29

+0.01
+0.11%

SLDB Ergebnisberichte

Positives Überraschungsverhältnis

SLDB übertreffen die 18 der letzten 32Schätzungen.

56%

Nächster Bericht

Datum des nächsten Berichts
04. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.51
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
+6.25%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-49.00%

Solid Biosciences Inc. Common Stock earnings per share and revenue

On 03. Nov. 2025, SLDB reported earnings of -0.48 USD per share (EPS) for Q3 25, missing the estimate of -0.44 USD, resulting in a -7.26% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -15.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analysts forecast an EPS of -0.51 USD, with revenue projected to reach -- USD, implying an increase of 6.25% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, Solid Biosciences Inc. Common Stock reported EPS of -$0.48, missing estimates by -7.26%, and revenue of $0.00, 0% as expectations.
The stock price moved down -15.29%, changed from $5.20 before the earnings release to $4.41 the day after.
The next earning report is scheduled for 04. März 2026.
Based on 16 analysts, Solid Biosciences Inc. Common Stock is expected to report EPS of -$0.51 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung